# Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women

> **NCT00590629** · PHASE4 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 43 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Niaspan

## Key facts

- **NCT ID:** NCT00590629
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590629, "Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00590629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*